HOME: Impact of Housing Transitions on Health Outcomes for Persons Experiencing Homelessness

Page last updated October 08, 2026

Study Design: Retrospective Observational Study
PCORnet Infrastructure: Common Data Model (CDM), Single IRB, Patient partners or engagement
Principal Investigator: Wyatt Bensken
Institution: OCHIN
PCORnet® Network Partner: ADVANCE
Funder: Federal (NIDDK/NIH)
Funding Date: 2026
Study Duration: 2026 – 2031
Therapeutic Area: Healthcare Delivery, Health Disparities, Metabolic Disorders
Status: Active, not recruiting

Research Question(s): How do transitions in housing impact diabetes and chronic kidney disease development, management, and progression for persons experiencing homelessness?

Choosing Immune Suppression in Renal Transplantation by Efficacy and Morbidity (CISTEM2)

Page last updated November 5, 2026

Study Design: Retrospective Observational Study
PCORnet Infrastructure: Common Data Model (CDM), Patient partners or engagement
Principal Investigator: Vikas Dharnidharka and David Axelrod
Institution: University of Missouri
PCORnet® Network Partner: GPC
Funder: Federal (NIDDK/NIH); (View on NIH Reporter)
Funding Date: 2024
Study Duration: 2024 - 2029
Participating PCORnet® Clinical Research Networks: GPC, OneFlorida+, STAR
Therapeutic Area: Nephrology
Status: Active, not recruiting

Research Question(s): 

  1. Can we identify optimal immunosuppression management strategies for kidney transplant patients leveraging real world data?

The COVID-19 and Diabetes Assessment (CODA) Study

Page last updated May 11, 2026

Study Website: https://codadiabetesstudy.org/ 
Study Design:
Prospective Observational Study
Principal Investigator: Russell Rothman
Institution: Vanderbilt University Medical Center
PCORnet® Network Partner: STAR
Funder: Federal (NIDDK/NIH)
Participating PCORnet® Clinical Research Networks: GPC, OneFlorida+, PaTH, PEDSnet, REACHnet, STAR
Therapeutic Area: Metabolic Disorders
Condition: COVID-19, Diabetes
Age Range: 18 Years and older (Adult, Older Adult)
Status: Recruiting

Research Question(s):  The study will answer important questions patients are asking about the link between diabetes and COVID-19.

  1. To what extent does COVID-19 cause worse glycemic control, vascular function, inflammation, and increased risk for blood clots in people with either type 1 or type 2 diabetes?
  2. The study will also explore the role of genomic, social, and environmental factors on metabolic function and the impact of COVID-19 infection and COVID-19 treatments on diabetes-related outcomes.